#VisualAbstract: Adjuvant ibandronate does not improve survival in postmenopausal patients with ER⁺ breast cancer
Click to read this study in the Journal of Clinical Oncology.
Tag: postmenopausal
Ribociclib plus letrozole provides greater overall survival benefit advanced breast cancer
1. Ribociclib plus letrozole provides significant overall survival benefit as compared to letrozole alone in patients with advanced breast cancer. ...
Fractional carbon dioxide laser not effective for treatment of postmenopausal vaginal symptoms
1. A randomized controlled trial of 85 participants found no significant difference in vaginal symptom severity after 12 months between ...
Two-year anastrozole treatment beneficial for disease-free survival in postmenopausal breast cancer
1. A five-year extension of anastrozole treatment was shown not to provide additional benefit compared to a two-year extension in ...
#VisualAbstract: Extended letrozole therapy improves disease-free survival in postmenopausal patients with breast cancer
Click to read the study in The Lancet Oncology.
Hormone therapy may not prevent atherosclerosis in menopausal women
1. In this randomized, controlled trial of healthy menopausal women, hormonal therapy did not slow the progression of atherosclerosis. 2. ...
Romosozumab significantly increases bone mineral density in postmenopausal women
Image: PD 1. Romosozumab, an anti-sclerostin antibody, significantly increased bone mineral density in postmenopausal women compared to placebo. 2. When ...
2 Minute Medicine Rewind September 30- October 6, 2013
Image: PD In this section, we will highlight the key high-impact studies, updates, and analyses published in medicine during the ...
Conjugated equine estrogens may elevate risk of venous thrombosis
Image: PD 1. Compared to oral estradiol use, oral conjugated equine estrogen (CEE) use was associated with an increased incidence ...
